Lotus Eye Hospital And Institute Ltd - Stock Valuation and Financial Performance

BSE: 532998 | NSE: LOTUSEYE | Hospital & Healthcare Services | Small Cap

Lotus Eye Hospital Share Price

56.30 -0.71 -1.25%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Lotus Eye Hospital

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

otus Eye Hospital And Institute stock performance -

mw4me loader
P/E Ratio (SA):
33.22
Market Cap:
117.5 Cr.
52-wk low:
44.1
52-wk high:
110.9

Is Lotus Eye Hospital And Institute Ltd an attractive stock to invest in?

1. Is Lotus Eye Hospital And Institute Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lotus Eye Hospital And Institute Ltd is a below average quality company.

2. Is Lotus Eye Hospital And Institute Ltd undervalued or overvalued?

The key valuation ratios of Lotus Eye Hospital And Institute Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Lotus Eye Hospital And Institute Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lotus Eye Hospital And Institute Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lotus Eye Hospital:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lotus Eye Hospital And Institute Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0.1%-3.8%0.4%1.1%3.6%1.7%3.4%3.1%5.8%7.5%-
Value Creation
Index
-1.0-1.3-1.0-0.9-0.7-0.9-0.8-0.8-0.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 28.729.931.1343838.440.632.438.94749
Sales YoY Gr.-4.2%4.1%9.1%12%1.1%5.5%-20.2%20.2%20.9%-
Adj EPS 0-10.10.20.80.30.80.71.421.7
YoY Gr.--4900%NA340%277.3%-59%120.6%-2.7%97.3%36.1%-
BVPS (₹) 24.723.823.824.124.424.124.725.326.327.728.6
Adj Net
Profit
0-20.10.51.70.71.61.534.14
Cash Flow from Ops. 4.42.43.435.84.252.74.44.4-
Debt/CF from Ops. 00.40.20.20.10.10.10.100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.7%4.4%5.1%20.9%
Adj EPS 66.4%18.8%37.7%36.1%
BVPS1.3%2.6%4%5.5%
Share Price 24.9% 20.5% 12.9% -6.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
0.1-40.20.93.41.43.12.95.67.36
Op. Profit
Mgn %
9.54.610.29.811.58.49.811.215.316.414.8
Net Profit
Mgn %
0.1-6.70.31.44.51.83.84.77.78.77.3
Debt to
Equity
0000000000-
Working Cap
Days
123115989396927288767159
Cash Conv.
Cycle
-34-1-1-9-7-6-9-12-735

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 6.00%

Net Profit is growing at healthy rate in last 3 years 37.74%

Sales growth has been subdued in last 3 years 5.07%

Sales growth is not so good in last 4 quarters at 4.50%

Latest Financials - Lotus Eye Hospital And Institute Ltd.

Standalone Consolidated
TTM EPS (₹) 1.7 -
TTM Sales (₹ Cr.) 48.5 -
BVPS (₹.) 28.6 -
Reserves (₹ Cr.) 39 -
P/BV 1.98 -
PE 33.22 -
From the Market
52 Week Low / High (₹) 44.10 / 110.90
All Time Low / High (₹) 4.43 / 110.90
Market Cap (₹ Cr.) 118
Equity (₹ Cr.) 20.8
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Lotus Eye Hospital:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.004.164.154.140.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Lotus Eye Hospital

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales29303134383841323947
Operating Expenses 26292831343537293339
Manufacturing Costs787799108910
Material Costs89911111112101215
Employee Cost 5567888779
Other Costs 5765667456
Operating Profit 3133434468
Operating Profit Margin (%) 9.5%4.6%10.2%9.8%11.4%8.4%9.8%11.2%15.2%16.4%
Other Income 0011111111
Interest 0000000000
Depreciation 3443332233
Exceptional Items 000000-1000
Profit Before Tax 0-200211246
Tax 0000000012
Profit After Tax 0-200211234
PAT Margin (%) 0.1%-6.6%0.3%1.3%4.6%1.8%2.6%4.8%7.7%8.7%
Adjusted EPS (₹)0.0-1.00.10.20.80.30.50.81.42.0
Dividend Payout Ratio (%)0%0%0%234%60%0%0%66%35%26%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 51494950515051535558
Share Capital 21212121212121212121
Reserves 31292929302930323437
Minority Interest0000000000
Debt0100000000
Long Term Debt0100000000
Short Term Debt0000000000
Trade Payables3333433343
Others Liabilities 4322323332
Total Liabilities 59565555575657586163

Fixed Assets

Gross Block69747575808182828790
Accumulated Depreciation22273134373639414346
Net Fixed Assets47474441434443414444
CWIP 0001000000
Investments 0000000000
Inventories4332222223
Trade Receivables0011111111
Cash Equivalents 11234371098
Others Assets6557765556
Total Assets 59565555575657586163

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 4233645344
PBT 0-200212246
Adjustment 3543322222
Changes in Working Capital 1-0-1-0111-1-1-2
Tax Paid 00000000-1-1
Cash Flow From Investing Activity -5-5-1-1-4-4-10-4-2
Capex -5-5-1-1-4-5-10-5-3
Net Investments 0000000000
Others 0000011111
Cash Flow From Financing Activity -12-10-2-100-2-2
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0100000000
Interest Paid 0000000000
Dividend Paid 0000-1000-1-1
Others -11000-1000-1
Net Cash Flow -10220-143-10
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)0.08-3.930.20.893.471.412.13.025.567.27
ROCE (%)0.27-4.140.271.133.711.663.324.07810.43
Asset Turnover Ratio0.50.520.560.620.680.680.720.560.650.76
PAT to CFO Conversion(x)INFN/AINFINF3451.51.331
Working Capital Days
Receivable Days4556996867
Inventory Days43413425202219221920
Payable Days15111911887108111881079682

Lotus Eye Hospital And Institute Ltd Stock News

Lotus Eye Hospital And Institute Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Lotus Eye Hospital on 28-Mar-2024 16:01 is ₹56.30.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Lotus Eye Hospital stood at ₹117.5.
The latest P/E ratio of Lotus Eye Hospital as of 28-Mar-2024 16:01 is 33.22.
The latest P/B ratio of Lotus Eye Hospital as of 28-Mar-2024 16:01 is 1.98.
The 52-week high of Lotus Eye Hospital is ₹110.9 and the 52-week low is ₹44.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lotus Eye Hospital is ₹48.50 ( Cr.) .

About Lotus Eye Hospital And Institute Ltd

Lotus Eye Care Hospital  was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.’on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited’ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.

Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception

Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.

In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.

Lotus has a vision of “empowering eyes to illuminate lives”. Lotus Eye Care group is marching towards its vision of becoming India’s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society.

Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India.

Services offered by the company:

  • Specialty Treatments 
  • Institute of Optometry 
  • Community ophthalmology  
  • Medical Tourism
  • Eye Bank

Milestones:

  • 1989- Opening of hospital at R.S.Puram, Coimbatore. The same was under management of LVRT from 1992 to 2006.
  • 2002- Opening of hospital at Peelamedu, Coimbatore
  • 2004 -Opening of hospital at Salem
  • 2007- Opening of hospital at Tirupur

Achievements/ recognition:

  • Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004.
  • In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
  • 2012 - Life Time Achievement Award to Dr.K.Sundramoorthy by The TamilnaduDr.M.G.R.Medical University.
  • 2014 - For the sake of Governor Award to Dr.K.Sundramoorthy by Rotary International.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.